Innovation Pharmaceuticals Eulerpool Uudised

Innovation Pharmaceuticals Eulerpool News

Innovation Pharmaceuticals aktsia uudised

Innovation Pharmaceuticals jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad Innovation Pharmaceuticals uudised paneme siia kokku.

• 28. august ·

  Yahoo
  Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024
• 21. juuni ·

  Yahoo
  Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases
• 5. juuni ·

  Yahoo
  Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing
• 17. aprill ·

  Yahoo
  Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications
• 9. aprill ·

  Nasdaq
  Weekly Preview: Earnings to Watch This Week 4-9-23 (C, DAL, JPM, TLRY)
• 15. märts ·

  Yahoo
  Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers
• 23. veebruar ·

  Yahoo
  Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission
• 5. veebruar ·

  Nasdaq
  Weekly Preview: Earnings to Watch This Week 2-5-23 (DIS, PEP, PYPL)
• 9. jaanuar ·

  Yahoo
  Innovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement
• 13. detsember ·

  Yahoo
  Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin’s Potential for Treating Fungal Keratitis